Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Neoplasms of the CNS

Free Subscription Articles published in Oncogene Retrieve available abstracts of 53 articles: HTML format

Single Articles

October 2025
1. UPRETI M, Petrosyan A, Thornton ME, Hovsepyan A, et al
   Multicellular tumor-stromal interactions recapitulate aspects of therapeutic response and human oncogenic signaling in a 3D disease model for H3K27M-altered DIPG.
   Oncogene. 2025;44:3694-3712.
   PubMed     Abstract available
   
   
   August 2025
2. LEE H, Kim D, Kim B, Shin E, et al
   Membrane flexibility induced by BST2 contributes to radioresistance in glioblastoma.
   Oncogene. 2025 Aug 18. doi: 10.1038/s41388-025-03544.
   PubMed     Abstract available
   
   
   
3. VIGNEUL E, Krins F, Clotman F
   Of travelling homeoproteins and medulloblastomas.
   Oncogene. 2025 Aug 4. doi: 10.1038/s41388-025-03523.
   PubMed     Abstract available
   
   
   July 2025
4. ZHANG S, Zhang L, Guan N, Feng X, et al
   Unveiling the role of TAM-derived extracellular vesicles in glioma progression through Treg polarization and immune suppression.
   Oncogene. 2025 Jul 18. doi: 10.1038/s41388-025-03497.
   PubMed     Abstract available
   
   
   
5. LIU L, Wang R, Cheng K, Bai C, et al
   Steroid receptor coactivator-1 facilitates METTL3-mediated m6A modification by coactivating NF-kappaB and promotes the malignant progression of glioblastoma.
   Oncogene. 2025 Jul 15. doi: 10.1038/s41388-025-03494.
   PubMed     Abstract available
   
   
   
6. MAHADDALKAR T, Banerjee A, Ketkar M, Thorat R, et al
   Aurora Kinase A and B inhibition abrogates 'Neosis', a non-mitotic cell division of GBM residual cells and prevents GBM recurrence.
   Oncogene. 2025;44:2103-2115.
   PubMed     Abstract available
   
   
   June 2025
7. BRISUDOVA P, Stojanovic D, Novak J, Nahacka Z, et al
   Correction: Functional mitochondrial respiration is essential for glioblastoma tumour growth.
   Oncogene. 2025 Jun 4. doi: 10.1038/s41388-025-03451.
   PubMed    
   
   
   May 2025
8. EL-SEHEMY A, Tachibana N, Ortin-Martinez A, Ringuette D, et al
   Importin-alpha transports Norrin to the nucleus to promote proliferation and Notch signaling in glioblastoma stem cells.
   Oncogene. 2025 May 27. doi: 10.1038/s41388-025-03427.
   PubMed     Abstract available
   
   
   
9. CHEN Y, Ding K, Zheng S, Gao S, et al
   Post-translational modifications in DNA damage repair: mechanisms underlying temozolomide resistance in glioblastoma.
   Oncogene. 2025 May 26. doi: 10.1038/s41388-025-03454.
   PubMed     Abstract available
   
   
   
10. BRISUDOVA P, Stojanovic D, Novak J, Nahacka Z, et al
    Functional mitochondrial respiration is essential for glioblastoma tumour growth.
    Oncogene. 2025 May 5. doi: 10.1038/s41388-025-03429.
    PubMed     Abstract available
    
    
    April 2025
11. LAKKA SS, Gondi CS, Yanamandra N, Olivero WC, et al
    Retraction Note: Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.
    Oncogene. 2025 Apr 29. doi: 10.1038/s41388-025-03402.
    PubMed    
    
    
    
12. GONDI CS, Lakka SS, Dinh DH, Olivero WC, et al
    Retraction Note to: RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas.
    Oncogene. 2025 Apr 29. doi: 10.1038/s41388-025-03403.
    PubMed    
    
    
    
13. LAKKA SS, Jasti SL, Gondi C, Boyd D, et al
    Retraction Note: Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro.
    Oncogene. 2025 Apr 25. doi: 10.1038/s41388-025-03397.
    PubMed    
    
    
    
14. REN F, Yi Y, Lu T, Liu X, et al
    Synthetic lethality through Gsk3beta inhibition in glioma stem cells via the WNT-WWC1-YAP axis.
    Oncogene. 2025 Apr 23. doi: 10.1038/s41388-025-03418.
    PubMed     Abstract available
    
    
    
15. ADACHI Y, Chandrasekar N, Kin Y, Lakka SS, et al
    Retraction Note: Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences.
    Oncogene. 2025 Apr 11. doi: 10.1038/s41388-025-03385.
    PubMed    
    
    
    
16. YANAMANDRA N, Gumidyala KV, Waldron KG, Gujrati M, et al
    Retraction Note: Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis.
    Oncogene. 2025 Apr 11. doi: 10.1038/s41388-025-03405.
    PubMed    
    
    
    
17. CHANDRASEKAR N, Mohanam S, Gujrati M, Olivero WC, et al
    Retraction Note to: Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells.
    Oncogene. 2025 Apr 11. doi: 10.1038/s41388-025-03406.
    PubMed    
    
    
    
18. GONDI CS, Lakka SS, Yanamandra N, Siddique K, et al
    Retraction Note: Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis.
    Oncogene. 2025 Apr 10. doi: 10.1038/s41388-025-03401.
    PubMed    
    
    
    
19. KONDURI SD, Rao CN, Chandrasekar N, Tasiou A, et al
    Retraction Note: A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion.
    Oncogene. 2025 Apr 10. doi: 10.1038/s41388-025-03404.
    PubMed    
    
    
    
20. KARGIOTIS O, Chetty C, Gondi CS, Tsung AJ, et al
    Retraction Note to: Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma.
    Oncogene. 2025 Apr 9. doi: 10.1038/s41388-025-03377.
    PubMed    
    
    
    
21. KONDURI SD, Osman FA, Rao CN, Srinivas H, et al
    Retraction Note: Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas.
    Oncogene. 2025 Apr 9. doi: 10.1038/s41388-025-03384.
    PubMed    
    
    
    
22. LAKKA SS, Rajan M, Gondi C, Yanamandra N, et al
    Retraction Note: Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion.
    Oncogene. 2025 Apr 9. doi: 10.1038/s41388-025-03395.
    PubMed    
    
    
    
23. MOHANAM S, Chintala SK, Go Y, Bhattacharya A, et al
    Retraction Note: In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor.
    Oncogene. 2025 Apr 8. doi: 10.1038/s41388-025-03393.
    PubMed    
    
    
    
24. YANAMANDRA N, Kondraganti S, Srinivasula SM, Gujrati M, et al
    Retraction Note: Activation of caspase-9 with irradiation inhibits invasion and angiogenesis in SNB19 human glioma cells.
    Oncogene. 2025 Apr 8. doi: 10.1038/s41388-025-03394.
    PubMed    
    
    
    
25. KOUL D, Parthasarathy R, Shen R, Davies MA, et al
    Retraction Note: Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN.
    Oncogene. 2025 Apr 8. doi: 10.1038/s41388-025-03396.
    PubMed    
    
    
    
26. MOHANAM S, Jasti SL, Kondraganti SR, Chandrasekar N, et al
    Retraction Note: Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells.
    Oncogene. 2025 Apr 4. doi: 10.1038/s41388-025-03379.
    PubMed    
    
    
    March 2025
27. FENG H, Liu KW, Guo P, Zhang P, et al
    Retraction Note: Dynamin 2 mediates PDGFRalpha-SHP-2-promoted glioblastoma growth and invasion.
    Oncogene. 2025 Mar 3. doi: 10.1038/s41388-025-03313.
    PubMed    
    
    
    February 2025
28. POWELL AM, Watson L, Luzietti L, Prekovic S, et al
    The epigenetic landscape of brain metastasis.
    Oncogene. 2025 Feb 27. doi: 10.1038/s41388-025-03315.
    PubMed     Abstract available
    
    
    
29. FENG H, Hu B, Vuori K, Sarkaria JN, et al
    Correction: EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180.
    Oncogene. 2025 Feb 5. doi: 10.1038/s41388-025-03290.
    PubMed    
    
    
    November 2024
30. SUN B, Wang G, Chen G, Zhang Y, et al
    GNAO1 overexpression promotes neural differentiation of glioma stem-like cells and reduces tumorigenicity through TRIM21/CREB/HES1 axis.
    Oncogene. 2024 Nov 23. doi: 10.1038/s41388-024-03234.
    PubMed     Abstract available
    
    
    
31. YU J, Han J, Yu M, Rui H, et al
    EZH2 inhibition sensitizes MYC-high medulloblastoma cancers to PARP inhibition by regulating NUPR1-mediated DNA repair.
    Oncogene. 2024 Nov 19. doi: 10.1038/s41388-024-03232.
    PubMed     Abstract available
    
    
    September 2024
32. DAVE F, Herrera K, Lockley A, van de Weijer LL, et al
    Correction: Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours.
    Oncogene. 2024 Sep 26. doi: 10.1038/s41388-024-03177.
    PubMed    
    
    
    August 2024
33. DAVE F, Herrera K, Lockley A, van de Weijer LL, et al
    Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours.
    Oncogene. 2024 Aug 23. doi: 10.1038/s41388-024-03131.
    PubMed     Abstract available
    
    
    
34. SONG Y, Zhang Y, Wang Z, Lin Y, et al
    CCL2 mediated IKZF1 expression promotes M2 polarization of glioma-associated macrophages through CD84-SHP2 pathway.
    Oncogene. 2024 Aug 7. doi: 10.1038/s41388-024-03118.
    PubMed     Abstract available
    
    
    
35. HU J, Li X, Xu K, Chen J, et al
    CircVPS8 promotes the malignant phenotype and inhibits ferroptosis of glioma stem cells by acting as a scaffold for MKRN1, SOX15 and HNF4A.
    Oncogene. 2024 Aug 4. doi: 10.1038/s41388-024-03116.
    PubMed     Abstract available
    
    
    July 2024
36. SHAH K, Tang Y, Breakefield X, Weissleder R, et al
    Correction: Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo.
    Oncogene. 2024 Jul 23. doi: 10.1038/s41388-024-03109.
    PubMed    
    
    
    May 2024
37. XU L, Ye Y, Tao Z, Wang T, et al
    Correction: O-GlcNAcylation of melanophilin enhances radiation resistance in glioblastoma via suppressing TRIM21 mediated ubiquitination.
    Oncogene. 2024 May 21. doi: 10.1038/s41388-024-03045.
    PubMed    
    
    
    
38. XIE W, Wang J, Tian S, Zhao H, et al
    RNF126-mediated ubiquitination of FSP1 affects its subcellular localization and ferroptosis.
    Oncogene. 2024;43:1463-1475.
    PubMed     Abstract available
    
    
    February 2024
39. SHENG H, Li H, Zeng H, Zhang B, et al
    Heterogeneity and tumoral origin of medulloblastoma in the single-cell era.
    Oncogene. 2024 Feb 14. doi: 10.1038/s41388-024-02967.
    PubMed     Abstract available
    
    
    November 2023
40. XU L, Ye Y, Tao Z, Wang T, et al
    O-GlcNAcylation of melanophilin enhances radiation resistance in glioblastoma via suppressing TRIM21 mediated ubiquitination.
    Oncogene. 2023 Nov 10. doi: 10.1038/s41388-023-02881.
    PubMed     Abstract available
    
    
    September 2023
41. TU KJ, Stewart CE, Hendrickson PG, Regal JA, et al
    Pooled genetic screens to identify vulnerabilities in TERT-promoter-mutant glioblastoma.
    Oncogene. 2023 Sep 23. doi: 10.1038/s41388-023-02845.
    PubMed     Abstract available
    
    
    August 2023
42. WAN S, Liu C, Li C, Wang Z, et al
    AKIP1 accelerates glioblastoma progression through stabilizing EGFR expression.
    Oncogene. 2023 Aug 18. doi: 10.1038/s41388-023-02796.
    PubMed     Abstract available
    
    
    July 2023
43. PAN JK, Lin WD, Kuo YL, Chen YC, et al
    ICAM2 initiates trans-blood-CSF barrier migration and stemness properties in leptomeningeal metastasis of triple-negative breast cancer.
    Oncogene. 2023 Jul 19. doi: 10.1038/s41388-023-02769.
    PubMed     Abstract available
    
    
    
44. NAVICKAS SM, Giles KA, Brettingham-Moore KH, Taberlay PC, et al
    The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target.
    Oncogene. 2023;42:2363-2373.
    PubMed     Abstract available
    
    
    June 2023
45. PIPERI C, Markouli M, Gargalionis AN, Papavassiliou KA, et al
    Deciphering glioma epitranscriptome: focus on RNA modifications.
    Oncogene. 2023 Jun 15. doi: 10.1038/s41388-023-02746.
    PubMed     Abstract available
    
    
    
46. EISENBARTH D, Wang YA
    Glioblastoma heterogeneity at single cell resolution.
    Oncogene. 2023 Jun 5. doi: 10.1038/s41388-023-02738.
    PubMed     Abstract available
    
    
    
47. LIANG XQ, Avraham HK, Jiang S, Avraham S, et al
    Retraction Note: Genetic alterations of the NRP/B gene are associated with human brain tumors.
    Oncogene. 2023 Jun 2. doi: 10.1038/s41388-023-02741.
    PubMed    
    
    
    
48. KAPOOR GS, O'Rourke DM
    Editorial Expression of Concern: SIRPa1 receptors interfere with the EGFRvIII signalosome to inhibit glioblastoma cell transformation and migration.
    Oncogene. 2023 Jun 1. doi: 10.1038/s41388-023-02740.
    PubMed    
    
    
    May 2023
49. WEI J, Wang L, Zhang Y, Sun T, et al
    TRIM25 promotes temozolomide resistance in glioma by regulating oxidative stress and ferroptotic cell death via the ubiquitination of keap1.
    Oncogene. 2023 May 15. doi: 10.1038/s41388-023-02717.
    PubMed     Abstract available
    
    
    
50. CORDNER R, Jhun M, Panwar A, Wang H, et al
    Glioma immunotherapy enhancement and CD8-specific sialic acid cleavage by isocitrate dehydrogenase (IDH)-1.
    Oncogene. 2023 May 9. doi: 10.1038/s41388-023-02713.
    PubMed     Abstract available
    
    
    
51. EL BABA R, Pasquereau S, Haidar Ahmad S, Monnien F, et al
    EZH2-Myc driven glioblastoma elicited by cytomegalovirus infection of human astrocytes.
    Oncogene. 2023 May 5. doi: 10.1038/s41388-023-02709.
    PubMed     Abstract available
    
    
    
52. PAASSEN I, Williams J, Rios Arceo C, Ringnalda F, et al
    Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities.
    Oncogene. 2023;42:1661-1671.
    PubMed     Abstract available
    
    
    March 2023
53. ZHOU P, Peng X, Tang S, Zhang K, et al
    E3 ligase MAEA-mediated ubiquitination and degradation of PHD3 promotes glioblastoma progression.
    Oncogene. 2023 Mar 7. doi: 10.1038/s41388-023-02644.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.